Aspen Aerogels Sees Unusually Large Options Volume (NYSE:ASPN)

Aspen Aerogels, Inc. (NYSE:ASPN) saw some unusual options trading on Monday. Traders bought 7,523 call options on the company. This represents an increase of approximately 135% compared to the average volume of 3,198 call options.

Insider Buying and Selling at Aspen Aerogels

In related news, CEO Donald R. Young sold 63,355 shares of the stock in a transaction on Monday, September 30th. The stock was sold at an average price of $30.03, for a total value of $1,902,550.65. Following the transaction, the chief executive officer now owns 483,640 shares of the company’s stock, valued at $14,523,709.20. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. In other Aspen Aerogels news, CFO Ricardo C. Rodriguez sold 32,465 shares of the firm’s stock in a transaction on Monday, August 26th. The shares were sold at an average price of $30.14, for a total transaction of $978,495.10. Following the transaction, the chief financial officer now directly owns 20,790 shares of the company’s stock, valued at approximately $626,610.60. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Donald R. Young sold 63,355 shares of Aspen Aerogels stock in a transaction dated Monday, September 30th. The shares were sold at an average price of $30.03, for a total transaction of $1,902,550.65. Following the completion of the sale, the chief executive officer now directly owns 483,640 shares in the company, valued at approximately $14,523,709.20. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 4.30% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in the business. Point72 Hong Kong Ltd bought a new position in shares of Aspen Aerogels in the second quarter valued at approximately $84,000. nVerses Capital LLC purchased a new stake in Aspen Aerogels in the 2nd quarter worth approximately $95,000. Quent Capital LLC purchased a new stake in Aspen Aerogels in the third quarter worth approximately $118,000. Banque Cantonale Vaudoise grew its holdings in shares of Aspen Aerogels by 37.5% during the 1st quarter. Banque Cantonale Vaudoise now owns 4,593 shares of the construction company’s stock valued at $81,000 after purchasing an additional 1,252 shares during the last quarter. Finally, Point72 DIFC Ltd bought a new position in shares of Aspen Aerogels during the second quarter valued at about $121,000. 97.64% of the stock is owned by institutional investors.

Aspen Aerogels Price Performance

NYSE:ASPN opened at $22.40 on Wednesday. The company has a current ratio of 3.46, a quick ratio of 2.82 and a debt-to-equity ratio of 0.23. The firm has a fifty day simple moving average of $25.51 and a 200 day simple moving average of $24.08. The stock has a market capitalization of $1.71 billion, a PE ratio of -50.23 and a beta of 2.16. Aspen Aerogels has a 1-year low of $6.62 and a 1-year high of $33.15.

Aspen Aerogels (NYSE:ASPN) last released its earnings results on Wednesday, August 7th. The construction company reported $0.21 EPS for the quarter, beating the consensus estimate of $0.05 by $0.16. The firm had revenue of $117.80 million for the quarter, compared to analyst estimates of $101.99 million. Aspen Aerogels had a net margin of 0.39% and a return on equity of 0.74%. The business’s quarterly revenue was up 144.4% compared to the same quarter last year. During the same period last year, the firm earned ($0.22) EPS. On average, research analysts expect that Aspen Aerogels will post 0.21 EPS for the current fiscal year.

Analysts Set New Price Targets

Several research firms have issued reports on ASPN. Craig Hallum boosted their price objective on shares of Aspen Aerogels from $33.00 to $38.00 and gave the stock a “buy” rating in a research note on Friday, June 14th. TD Cowen boosted their price objective on Aspen Aerogels from $36.00 to $41.00 and gave the stock a “buy” rating in a research report on Tuesday, August 20th. HC Wainwright boosted their price objective on Aspen Aerogels from $25.00 to $30.00 and gave the stock a “buy” rating in a research note on Friday, August 9th. Roth Mkm restated a “buy” rating and issued a $36.00 target price on shares of Aspen Aerogels in a report on Wednesday, August 21st. Finally, Benchmark reiterated a “buy” rating and set a $14.00 price objective on shares of Aspen Aerogels in a research report on Thursday, August 8th. One equities research analyst has rated the stock with a sell rating, nine have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $29.70.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.